In a large cohort comprising 1554 Brazilian breast cancer patients referred for genetic testing at a single clinical diagnostic laboratory in Brazil, 9.84% were found to be BRCA1 or BRCA2 mutation carriers independent of age (30). The gene discussed is BRCA1; the disease is breast cancer.